Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Joan M. Spellman"'
Autor:
Joan M. Spellman, Lori K. Weimer, Zhongyou Wei, Steven T. Miller, Daniel A. Gamache, John M. Yanni
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 18:349-361
The mucin secretagogue 15(S)-HETE was found to stimulate glycoprotein secretion in human ocular tissue at submicromolar concentrations in the present studies. Therefore, the ability of topically applied 15(S)-HETE to preserve corneal integrity was in
Publikováno v:
Acta Ophthalmologica Scandinavica. 78:10-15
Olopatadine is a human conjunctival mast cell stabilizer with antihistaminic activity. Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have additional pharmacological properties. The interactions of these two
Publikováno v:
Inflammation. 24:357-370
Nepafenac, the amide analog of 2-amino-3-benzoylbenzeneacetic acid (amfenac), was examined in preclinical models for its potential utility as a topical ocular anti-inflammatory agent. Diclofenac was selected as the reference compound. In contrast to
Publikováno v:
Inflammation. 24:371-384
Nepafenac, the amide analog of the NSAID amfenac, was examined in vitro for its bioactivation by ocular tissue components and its ability to permeate external ocular barriers. Rabbit tissues catalyzed a concentration-dependent conversion of nepafenac
Autor:
Daniel A. Gamache, Najam A. Sharif, Joan M. Spellman, John M. Yanni, Lori K. Weimer, Steven T. Miller
Publikováno v:
Acta Ophthalmologica Scandinavica. 77:33-37
Two important realizations about pathophysiological mechanisms involved in allergic conjunctivitis have led to novel drug discovery efforts and new topical ocular medications for prevention and treatment of this prevent allergic disease. The first of
Autor:
Steven T. Miller, Daniel A. Gamache, John M. Yanni, Shouxi Xu, Joan M. Spellman, Najam A. Sharif
Publikováno v:
Annals of Allergy, Asthma & Immunology. 79:541-545
Background The concept of mast cell heterogeneity is well established. Recent data indicate that human conjunctival tissue mast cells and human connective tissue mast cells respond to various secretagogues in similar fashion. It is now recognized tha
Autor:
Joan M. Spellman, Gustav Graff, S. Dan Dimitrijevich, Laura Smith Lang, Lori K. Weimer, John M. Yanni, Daniel A. Gamache
Publikováno v:
Ocular Immunology and Inflammation. 5:117-128
The production of cytokines by human conjunctival epithelial cells following stimulation was investigated. Primary cultures of human conjunctival epithelial cells were characterized by morphology and keratin expression. Cultured epithelial cells were
Publikováno v:
International Archives of Allergy and Immunology. 114:139-143
Mast cells have been identified in the choroid of numerous species including man. However, functional studies involving these human mast cells have not been reported. In the current studies, the secretory response of human choroidal mast cells to var
Publikováno v:
Ocular Immunology and Inflammation. 4:39-50
Human conjunctiva was enzymatically digested into monodispersed cell preparations using collagenase and hyaluronidase. The preparations were enriched for mast cells using Percoll gradient centrifugation prior to challenge with various secretagogues.
Autor:
Gustav Graff, Joan M. Spellman, L S Lang, D.W. Parnell, Lori K. Weimer, Steven T. Miller, Milton T. Brady, D.J. Stephens, John M. Yanni, Daniel A. Gamache
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 12:389-400
Olopatadine (AL-4943A; KW-4679) [(z)-11-[3-(dimethylamino)propylidene]-6, 11-dihydrodibenz[b,e]oxepine-2 acetic acid hydrochloride] is an anti-allergic agent which inhibits mast cell mediator release and possesses histamine H1 receptor antagonist act